Published in Immunology on April 01, 1977
Age-dependent variations of antibody avidity. Immunology (1978) 1.13
Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. I. Enhancement of T cell-mediated immune responses of mice. Clin Exp Immunol (1979) 0.83
Vitamin E and immune response. I. Enhancement of helper T cell activity by dietary supplementation of vitamin E in mice. Immunology (1979) 0.79
T-cell-dependent oscillations of IgM antibody affinity during the immune response to DNP-Dextran to low or high epitope density. Immunology (1982) 0.75
In vitro immune response of spleen cells from mice genetically selected for high or low antibody production. Immunology (1978) 0.75
Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med (1969) 18.89
Plaque Formation in Agar by Single Antibody-Producing Cells. Science (1963) 10.20
The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol (1972) 9.43
Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05
Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med (1971) 4.29
An in vitro primary immune response to 2,4,6-trinitrophenyl substituted erythrocytes: response against carrier and hapten. J Immunol (1970) 3.63
The carrier effect in the secondary response to hapten-protein conjugates. I. Measurement of the effect with transferred cells and objections to the local environment hypothesis. Eur J Immunol (1971) 3.59
Properties of primed suppressor T cells and their products. Transplant Rev (1975) 3.42
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
Genetic control of the immune response. The effect of thymectomy on the primary and secondary antibody response of mice to poly-L(tyr, glu)-poly-D, L-ala--poly-L-lys. J Exp Med (1972) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Studies on the regulation of avidity at the level of the single antibody-forming cell. The effect of antigen dose and time after immunization. J Exp Med (1970) 2.74
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59
Tolerance, enhancement and the regulation of interactions between T cells, B cells and macrophages. Transplant Rev (1972) 2.44
Differential stimulation of precursor cells and carrier-specific thymus-derived cell activity in the in vivo reponse to heterologous erythrocytes in mice. J Immunol (1972) 2.21
Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. J Immunol (1971) 2.19
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J Exp Med (1968) 1.89
Selective roles of thymus-derived lymphocytes in the antibody response. II. Preferential suppression of high-affinity antibody-forming cells by carrier-primed suppressor T cells. J Exp Med (1974) 1.46
Enhancing activity of thymocyte culture cell-free medium on the in vitro immune response of spleen cells from neonatally thymectomized mice to sheep RBC. J Immunol (1972) 1.34
Increase and decrease in binding affinity of antibodies during the immune response. Immunochemistry (1972) 1.22
Dual regulatory role of the thymus in the maturation of immune response in the rabbit. J Exp Med (1974) 1.07
Thymus dependence of the immune response: response to the haptenic determinant NIP in mice. Immunology (1971) 1.05
Studies on antibody avidity at the cellular level. Effects of immunological paralysis and administered antibody. Eur J Immunol (1971) 1.00
The rise and fall of antibody avidity at the level of single immunocytes. J Immunol (1972) 0.93
The effect of carrier-primed cells on an adoptive anti-hapten response. Eur J Immunol (1971) 0.88
Affinity and Ig classes of anti-hapten antibodies in carrier-preimmunized rats. Eur J Immunol (1973) 0.86
Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol (1970) 2.06
Mechanisms influencing the immunodominance of T cell determinants. J Exp Med (1988) 1.91
Regulation of the macrophage content of neoplasms by chemoattractants. Science (1983) 1.83
Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol (1983) 1.82
Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res (1990) 1.77
Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol (1984) 1.75
Morphological characterization of a cell population responsible for natural killer activity. Immunology (1981) 1.73
Natural killer activity of gut mucosal lymphoid cells in mice. Eur J Immunol (1981) 1.73
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature (1984) 1.71
Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.51
Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. J Immunol (1979) 1.48
Enhancing activity of thymocyte culture cell-free medium on the in vitro immune response of spleen cells from neonatally thymectomized mice to sheep RBC. J Immunol (1972) 1.34
Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions. J Reticuloendothel Soc (1979) 1.31
A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30
IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J Immunol (1986) 1.30
Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature (1989) 1.26
IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. J Immunol (1984) 1.24
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol (1998) 1.24
Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons. J Immunol (1985) 1.17
In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J Immunol (1987) 1.16
Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J Immunol (1985) 1.16
Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol (1985) 1.15
Age-dependent variations of antibody avidity. Immunology (1978) 1.13
Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains. Cell Immunol (1979) 1.11
In vitro primary immune response resulting from the interaction between bone marrow-derived and thymus cells. Experientia (1970) 1.10
Use of hematopoietic cytokines to accelerate the recovery of the immune system in irradiated mice. Exp Hematol (1997) 1.10
IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation. Int Immunol (1996) 1.10
Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol (1989) 1.09
Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses. Int J Immunopharmacol (1981) 1.08
Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. J Immunol (1979) 1.07
Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol (1993) 1.06
Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells. FEBS Lett (1989) 1.05
Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett (2001) 1.05
In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology (1985) 1.05
IFN-beta-induced reduction of superoxide anion generation by macrophages. Immunology (1982) 1.04
Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines. Eur J Immunol (1981) 1.04
Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J Immunol (1989) 1.03
Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem (1997) 1.02
Defective tumoricidal capacity of macrophages from A/J mice. III. Genetic analysis of the macrophage defect. J Immunol (1980) 1.02
The effect of thymic action on the precursors of antigen-sensitive cells. Proc Natl Acad Sci U S A (1967) 1.02
Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness. J Immunol (1980) 1.02
Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol (1984) 1.02
Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon. J Immunol (1987) 1.01
Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues. Am J Pathol (1989) 1.01
Enhancement of in vivo immune response by tumor necrosis factor. J Immunol (1987) 1.00
Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab (1969) 1.00
A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J Immunol Methods (1986) 1.00
Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: evidence for a role in the regulation of the macrophage content of neoplastic tissues. Int J Cancer (1983) 0.99
In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice. J Immunol (1988) 0.98
Heterogeneity of mouse myeloma gamma G globulins as revealed by enzymatic proteolysis. J Immunol (1969) 0.98
Selective effects of ionizing radiations on immunoregulatory cells. Immunol Rev (1982) 0.97
Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth-muscle cells. Am J Respir Crit Care Med (1997) 0.96
Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. J Immunol (1980) 0.96
Thymus dependence of adoptive immunity in irradiated mice. Transplantation (1968) 0.94
In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta. J Exp Med (1988) 0.93
Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology (1983) 0.93
The rise and fall of antibody avidity at the level of single immunocytes. J Immunol (1972) 0.93
The membrane form of the type II IL-1 receptor accounts for inhibitory function. J Immunol (2000) 0.93
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production. J Immunol (1985) 0.93
Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages. Clin Exp Immunol (1984) 0.93
Water characteristics associated with the occurrence of Legionella pneumophila in dental units. Eur J Oral Sci (2000) 0.92
Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice. Clin Exp Immunol (1984) 0.92
Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology (1991) 0.91
Gangliosides and neurological diseases. BMJ (1993) 0.90
Cytokine-associated tissue injury and lethality in mice: a comparative study. Clin Immunol Immunopathol (1991) 0.90
Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines. Infect Immun (1988) 0.89
Rearrangement and expression of the alpha- and beta-chain genes of the T-cell antigen receptor in functional murine suppressor T-cell clones. Proc Natl Acad Sci U S A (1985) 0.88
Defective antigen presentation by macrophages from mice genetically selected for low antibody response. Eur J Immunol (1981) 0.88
The metabolism of different immunoglobulin classes in irradiated mice. 3. Effects of supra-lethal doses of x-rays. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 0.88
Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor. J Immunol (2000) 0.88
Synergism between two helper cell subpopulations characterized by different radiosensitivity and nylon adherence. J Immunol (1981) 0.88
Synthesis and antiulcer activity of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo [1,5-a]pyrimidine-7-ones. Farmaco Sci (1986) 0.88
Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann N Y Acad Sci (1994) 0.87
Production of antigen-specific suppressive T cell factor by radiation leukemia virus-transformed suppressor T cells. Proc Natl Acad Sci U S A (1981) 0.86
Interferons inhibit LTC4 production in murine macrophages. J Immunol (1987) 0.86
Biological effects of Escherichia coli lipopolysaccharide (LPS) in vivo. II. Selection in the mouse thymus of PHA- and con A-responsive cells. Immunology (1976) 0.86
Differential effects of gonadectomy on thymic stromal cells in promoting T cell differentiation in mice. Mech Ageing Dev (1995) 0.86
Recovery of the hemolysin response in mouse radiation chimeras. Transplantation (1968) 0.86
Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood cells. Bone Marrow Transplant (2000) 0.86
Immunoregulation of lysozyme-specific suppression. II. Hen egg-white lysozyme-specific monoclonal suppressor T cell factor suppresses the afferent phase of delayed-type hypersensitivity and induces second-order suppressor T cells. Eur J Immunol (1984) 0.86
Development of cell-mediated antiviral immunity and macrophage activation in C3H/HeN mice infected with mouse mammary tumor virus. J Immunol (1980) 0.85
Neuropeptide Y plasma levels and immunological changes during academic stress. Neuropsychobiology (1999) 0.85
Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain. J Immunol (2001) 0.85
Fine antigenic specificity and genetic restriction of lysozyme-specific suppressor T cell factor produced by radiation leukemia virus-transformed suppressor T cells. Eur J Immunol (1982) 0.85
Regulation of macrophage suppression and cytotoxicity by interferon role of Ia-bearing macrophages. J Immunol (1982) 0.85
Phosphatidylserine-induced modulation of the immune response in mice: effect of intravenous administration. Immunopharmacology (1990) 0.85
Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria. Cytokine (2013) 0.84
Binding of IL-1 beta to IL-1R type II at single cell level. J Immunol (1991) 0.84
Genetics of chemical carcinogenesis. 1. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogenesis (1990) 0.84
Natural antibacterial activity against Salmonella typhi in human cord blood. J Immunol (1989) 0.84